Stock Earnings

Question 1

What are Liminatus Pharma Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Liminatus Pharma Inc has a total asset of $5, Net loss of $-3

Question 2

What are the key financial ratios for LIMN?

Accepted Answer

Liminatus Pharma Inc's Current ratio is 0.2, has a Net margin is 0, sales per share of $0.

Question 3

How is Liminatus Pharma Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Liminatus Pharma Inc data is not available.

Question 4

Is Liminatus Pharma Inc profitable?

Accepted Answer

no, according to the latest financial statements, Liminatus Pharma Inc has a net loss of $-3

Question 5

Does Liminatus Pharma Inc have any liabilities?

Accepted Answer

yes, Liminatus Pharma Inc has liability of 24

Question 6

How many outstanding shares for Liminatus Pharma Inc?

Accepted Answer

Liminatus Pharma Inc has a total outstanding shares of 26.01

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022
Revenue	0	0	0	0
Revenue Growth (YoY)	--	--	--	--
Cost of Revenue	--	--	--	--
Gross Profit	--	--	--	--
Selling, General & Admin	2	0	1	0
Research & Development	0	2	3	1
Operating Expenses	2	3	4	2
Other Non Operating Income (Expenses)	-2	0	0	0
Pretax Income	-2	-3	-4	-2
Income Tax Expense	--	0	0	0
Net Income	-2	-3	-4	-2
Net Income Growth	--	-25%	100%	--
Shares Outstanding (Diluted)	26.01	26.01	26.01	26.01
Shares Change (YoY)	--	0%	0%	--
EPS (Diluted)	-0.11	-0.13	-0.19	-0.11
EPS Growth	--	-28.99%	70%	--
Free Cash Flow	-10	-1	-3	0
Free Cash Flow Per Share	-0.38	-0.03	-0.11	0
Gross Margin	--	--	--	--
Operating Margin	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%
EBITDA	-2	--	--	--
EBITDA Margin	0%	--	--	--
D&A For EBITDA	0	--	--	--
EBIT	-2	-3	-4	-2
EBIT Margin	0%	0%	0%	0%
Effective Tax Rate	--	0%	0%	0%

Liminatus Pharma Inc (LIMN) Price